James P. Kemp, MDa, David A. Cook, MDb, Gary A

Slides:

Advertisements

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Advertisements

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc

Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes

Kiwi fruit allergy: A new birch pollen–associated food allergy

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction Robert A. Nathan, MDa, Jonathan A.

Kiwi fruit allergy: A new birch pollen–associated food allergy

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children Mark Boguniewicz, MDa, Virginia C. Fiedler,

Richard L. ZuWallack, MD a,b, James P

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate Raif S. Geha, MDa, Alexa Beiser,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia Carol K. Fosso, MDa,

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Elinor Simons, MDa, William M

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial William Busse, MDa,

The impact of allergic rhinitis on bronchial asthma

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.

Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol Henry Milgrom, MDa, David P. Skoner,

Peter M. Wolfgram, MD, David B. Allen, MD

Side effects of inhaled corticosteroids

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma Gail.

Practice Notes from the AAAAI

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.

Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel.

Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray Eli O. Meltzer,

Jack M. Becker, MDa, Anjali Arora, MDb, Richard J

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients.

Thomas B. Casale, MDa, I. Leonard Bernstein, MDb, William W

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma Gordon D. Raphael, MDa, Robert.

News & Notes Journal of Allergy and Clinical Immunology

The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis Anjuli S. Nayak, MDa, Mark H.

Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma

Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma Eugene R. Bleecker, MDa, Michael J. Welch, MDb,

Occupational allergy caused by urticating hair of Brazilian spider

Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma Michael Schatz, MD, MSa, E.Francis Cook, DScb, Randy Nakahiro,

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,

A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room Dann K. Heilman,

Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Practice Notes from the AAAI

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma James P.

Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing.

Anaphylaxis after initial ingestion of rambutan, a tropical fruit

Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure Susan Colilla, PhDa*, Dan Nicolae, PhDb, Anna Pluzhnikov,

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Footnotes1 Journal of Allergy and Clinical Immunology

National trends in asthma visits and asthma pharmacotherapy,

Larry C. Borish, MDa, Harold S

Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression

Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial Eli O. Meltzer, MDa,

News & Notes Journal of Allergy and Clinical Immunology

Desloratadine: A new, nonsedating, oral antihistamine

Presentation transcript:

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids James P. Kemp, MDa, David A. Cook, MDb, Gary A. Incaudo, MDc, Jonathan Corren, MDd, Chris Kalberg, PhDe, Amanda Emmett, MSe, Fred M. Cox, PhDe, Kathleen Rickard, MDe Journal of Allergy and Clinical Immunology Volume 101, Issue 2, Pages 188-195 (February 1998) DOI: 10.1016/S0091-6749(98)70383-5 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Change in asthma quality-of-life scores from baseline to week 12. *p < 0.001; †p = 0.006. Journal of Allergy and Clinical Immunology 1998 101, 188-195DOI: (10.1016/S0091-6749(98)70383-5) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Percent of days without symptoms. *p < 0.001. Journal of Allergy and Clinical Immunology 1998 101, 188-195DOI: (10.1016/S0091-6749(98)70383-5) Copyright © 1998 Mosby, Inc. Terms and Conditions